SCHEMBL12374423

SCHEMBL12374423

C=CC(=O)OCCCOc1ccc(C(=O)OCCc2ccc(OC(=O)c3ccc(OCCCOC(=O)C=C)cc3)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 3/20 0.49
MAPT P10636 6/20 0.47
NPC1 O15118 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
RAB9A P51151 2/20 0.47
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
PRSS1 P07477 1/20 0.41
ACR P10323 1/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18353288 1.00 THRB (0.49) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL20616102 0.98 THRB (0.49) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL20672698 0.98 THRB (0.49) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL22138769 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL22138764 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL20615638 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL20615639 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL816901 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL20616090 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A
SCHEMBL20616070 0.96 THRB (0.48) THRBMAPTNPC1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370740-B2 Method for producing ester group-containing compound DIC CORPORATION (JP) 2022-06-28 US disclosed
US-20210108142-A1 POLARIZED LUMINESCENT FILM DIC CORPORATION (JP) 2021-04-15 US disclosed
EP-3088426-B1 COMPOUND CONTAINING MESOGENIC GROUP, AND MIXTURE, COMPOSITION, AND OPTICALLY ANISOTROPIC BODY USING SAID COMPOUND DAINIPPON INK & CHEMICALS (JP) 2021-03-24 EP disclosed
US-10788715-B2 Photo-alignment material and photo-alignment method TOKYO INSTITUTE OF TECHNOLOGY (JP) 2020-09-29 US disclosed
US-20200264461-A1 LIGHT CONVERSION FILM AND IMAGE DISPLAY DEVICE DIC CORPORATION (JP) 2020-08-20 US disclosed
US-20200199452-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL FILM INCLUDING THE SAME, AND METHOD FOR PRODUCING OPTICAL FILM DIC CORPORATION (JP) 2020-06-25 US disclosed
US-10655066-B2 Optical isomer DIC CORPORATION (JP) 2020-05-19 US disclosed
US-10473820-B2 Compound containing mesogenic group, and mixture, composition, and optically anisotropic body using said compound DIC CORPORATION (JP) 2019-11-12 US disclosed
US-10253125-B2 Polymerizable liquid crystal composition and optically anisotropic body, retardation film, and patterned retardation film using the same DIC CORPORATION (JP) 2019-04-09 US disclosed
US-20190086738-A1 PHOTO-ALIGNMENT MATERIAL AND PHOTO-ALIGNMENT METHOD TOKYO INSTITUTE OF TECHNOLOGY (JP) 2019-03-21 US disclosed
US-20100189930-A1 COMPOSITION FOR PHOTO-ALIGNMENT FILM, PHOTO-ALIGNMENT FILM, AND OPTICALLY ANISOTROPIC MEDIUM DIC CORPORATION (JP) 2010-07-29 US disclosed
US-20100149446-A1 POLYMER-STABILIZED LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY DEVICE DIC CORPORATION (JP) 2010-06-17 US disclosed
US-20100149446-A1 POLYMER-STABILIZED LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY DEVICE DIC CORPORATION (JP) 2010-06-17 US disclosed
EP-2138518-A1 POLYMER-STABILIZED LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY, AND PROCESS FOR PRODUCTION OF LIQUID CRYSTAL DISPLAY DIC Corporation (JP) 2009-12-30 EP disclosed
US-20090269513-A1 PHOTOALIGNMENT FILM COMPOSITION, OPTICALLY ANISOTROPIC MEDIUM AND METHOD FOR PREPARING THEREOF DIC CORPORATION (JP) 2009-10-29 US disclosed
US-20090269513-A1 PHOTOALIGNMENT FILM COMPOSITION, OPTICALLY ANISOTROPIC MEDIUM AND METHOD FOR PREPARING THEREOF DIC CORPORATION (JP) 2009-10-29 US disclosed
EP-1947489-A1 COMPOSITION FOR PHOTO-ALIGNMENT FILM, OPTICALLY ANISOTROPIC MATERIAL AND METHOD FOR PRODUCING SAME DIC Corporation (JP) 2008-07-23 EP disclosed
US-20080036946-A1 Optical Film, Elliptically Polarizing Plate, Circularly Polarizing Plate, Liquid Crystal Display Element, and Method of Producing Optical Film DAINIPPON INK AND CHEMICALS, INC. (JP) 2008-02-14 US disclosed
US-20080036946-A1 Optical Film, Elliptically Polarizing Plate, Circularly Polarizing Plate, Liquid Crystal Display Element, and Method of Producing Optical Film DAINIPPON INK AND CHEMICALS, INC. (JP) 2008-02-14 US disclosed
EP-1840604-A1 OPTICAL FILM, ELLIPTICALLY POLARIZING PLATE, CIRCULARLY POLARIZING PLATE, LIQUID CRYSTAL DISPLAY ELEMENT AND METHOD FOR MANUFACTURING SUCH OPTICAL FILM Dainippon Ink and Chemicals, Incorporated (JP) 2007-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11370740-B2 Method for producing ester group-containing compound COASY, TAF5, TAF9 THRB 4843/4885MAPT 782/4885NPC1 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.